An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer's disease.
Kainuma M, Ouma S, Kawakatsu S, Iritani O, Yamashita KI, Ohara T, Hirano S, Suda S, Hamano T, Hieda S, Yasui M, Yoshiiwa A, Shiota S, Hironishi M, Wada-Isoe K, Sasabayashi D, Yamasaki S, Murata M, Funakoshi K, Hayashi K, Shirafuji N, Sasaki H, Kajimoto Y, Mori Y, Suzuki M, Ito H, Ono K, Tsuboi Y.
Kainuma M, et al. Among authors: funakoshi k.
Front Pharmacol. 2022 Oct 14;13:991982. doi: 10.3389/fphar.2022.991982. eCollection 2022.
Front Pharmacol. 2022.
PMID: 36313371
Free PMC article.